Canada markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.15+0.48 (+1.52%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 56.4B
Enterprise Value 36.15B
Trailing P/E N/A
Forward P/E 1-41.22
PEG Ratio (5 yr expected) 132.42
Price/Sales (ttm)69.33
Price/Book (mrq)22.72
Enterprise Value/Revenue 366.68
Enterprise Value/EBITDA 7-62.16

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 3722.25%
S&P500 52-Week Change 333.41%
52 Week High 353.69
52 Week Low 33.74
50-Day Moving Average 330.95
200-Day Moving Average 331.83

Share Statistics

Avg Vol (3 month) 32.37M
Avg Vol (10 day) 32.06M
Shares Outstanding 5199.01M
Implied Shares Outstanding 6N/A
Float 186.83M
% Held by Insiders 16.80%
% Held by Institutions 183.45%
Shares Short (Jul. 14, 2021) 412.23M
Short Ratio (Jul. 14, 2021) 46
Short % of Float (Jul. 14, 2021) 47.95%
Short % of Shares Outstanding (Jul. 14, 2021) 46.15%
Shares Short (prior month Jun. 14, 2021) 413.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021


Profit Margin -64.25%
Operating Margin (ttm)-114.19%

Management Effectiveness

Return on Assets (ttm)-8.85%
Return on Equity (ttm)-34.78%

Income Statement

Revenue (ttm)92.29M
Revenue Per Share (ttm)0.53
Quarterly Revenue Growth (yoy)85.90%
Gross Profit (ttm)32.57M
EBITDA -99.01M
Net Income Avi to Common (ttm)-59.29M
Diluted EPS (ttm)-0.34
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.16B
Total Cash Per Share (mrq)5.85
Total Debt (mrq)936.61M
Total Debt/Equity (mrq)333.84
Current Ratio (mrq)35.45
Book Value Per Share (mrq)1.41

Cash Flow Statement

Operating Cash Flow (ttm)-78.96M
Levered Free Cash Flow (ttm)-142.65M